BR112012031667A2 - composição - Google Patents
composiçãoInfo
- Publication number
- BR112012031667A2 BR112012031667A2 BR112012031667A BR112012031667A BR112012031667A2 BR 112012031667 A2 BR112012031667 A2 BR 112012031667A2 BR 112012031667 A BR112012031667 A BR 112012031667A BR 112012031667 A BR112012031667 A BR 112012031667A BR 112012031667 A2 BR112012031667 A2 BR 112012031667A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B13/00—Preparation of cellulose ether-esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/08—Cellulose derivatives
- C08L1/32—Cellulose ether-esters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35452510P | 2010-06-14 | 2010-06-14 | |
PCT/US2011/040222 WO2011159626A1 (en) | 2010-06-14 | 2011-06-13 | Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012031667A2 true BR112012031667A2 (pt) | 2016-11-08 |
Family
ID=44627135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012031667A BR112012031667A2 (pt) | 2010-06-14 | 2011-06-13 | composição |
Country Status (11)
Country | Link |
---|---|
US (1) | US9040033B2 (pt) |
EP (1) | EP2579896B1 (pt) |
JP (1) | JP5792807B2 (pt) |
KR (1) | KR101807338B1 (pt) |
CN (1) | CN103153343B (pt) |
BR (1) | BR112012031667A2 (pt) |
CA (1) | CA2801712A1 (pt) |
CO (1) | CO6660473A2 (pt) |
IL (1) | IL223607A (pt) |
MX (1) | MX2012014849A (pt) |
WO (1) | WO2011159626A1 (pt) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US20140088164A1 (en) | 2010-11-24 | 2014-03-27 | Rib-X Pharmaceuticals, Inc. | Pharmaceutical Compositions |
EP2802354A4 (en) * | 2012-01-09 | 2015-07-29 | Virginia Tech Intell Prop | CELLULOSE DERIVATIVES FOR INHIBITING THE CRYSTALLIZATION OF MEDIALLY SOLUBLE DRUGS IN WATER |
KR102041766B1 (ko) * | 2012-03-27 | 2019-11-07 | 다우 글로벌 테크놀로지스 엘엘씨 | 셀룰로스 에테르의 에스테르의 제조방법 |
WO2013154607A1 (en) | 2012-04-11 | 2013-10-17 | Dow Global Technologies Llc | Esterified cellulose ethers having a specific substituent distribution |
CN102807625A (zh) * | 2012-08-23 | 2012-12-05 | 浙江中维药业有限公司 | 一种醋酸羟丙甲纤维素琥珀酸酯的制备方法 |
US10730957B2 (en) | 2012-08-24 | 2020-08-04 | Dow Global Technologies Llc | Process of preparing an esterified cellulose ether in the presence of an alkali metal carboxylate and an aliphatic carboxylic acid |
BR112015002055A2 (pt) * | 2012-08-24 | 2017-07-04 | Dow Global Technologies Llc | acetato succinato de hidroxialquil metil celulose, composição, dispersão sólida, processo para produzir uma dispersão sólida, forma de dosagem e cápsula de envoltório |
US20150203595A1 (en) * | 2012-08-24 | 2015-07-23 | Dow Global Technologies Llc | Process for preparing an ester of a cellulose ether in the presence of an alkali metal carboxylate |
WO2014031447A1 (en) | 2012-08-24 | 2014-02-27 | Dow Global Technologies Llc | Process for preparing an ester of a cellulose ether in the presence of an aliphatic carboxylic acid |
CN104736572B (zh) | 2012-08-24 | 2017-09-05 | 陶氏环球技术有限责任公司 | 部分交联的酯化纤维素醚 |
EP2961775B1 (en) | 2013-03-01 | 2020-04-08 | Hercules LLC | Pharmaceutical compositions with enhanced performance and improved processability |
WO2014137777A1 (en) | 2013-03-07 | 2014-09-12 | Dow Global Technologies Llc | Novel esterified cellulose ethers of low viscosity |
US20150368365A1 (en) * | 2013-03-07 | 2015-12-24 | Dow Global Technologies Llc | Novel esterified cellulose ethers of low viscosity and high molecular weight |
WO2014137778A1 (en) | 2013-03-07 | 2014-09-12 | Dow Global Technologies Llc | Novel esterified cellulose ethers of very low viscosity |
US9890220B2 (en) * | 2013-03-07 | 2018-02-13 | Dow Global Technologies Llc | Esterified cellulose ethers of very high molecular weight |
JP6306691B2 (ja) | 2013-05-14 | 2018-04-04 | ダウ グローバル テクノロジーズ エルエルシー | ジカルボン酸を用いたエステル化セルロースエーテル |
KR101918327B1 (ko) * | 2013-06-03 | 2018-11-13 | 신에쓰 가가꾸 고교 가부시끼가이샤 | 가열 용융 압출용 조성물 및 이를 이용한 가열 용융 압출 성형물의 제조 방법 |
CN105829352B (zh) | 2013-09-23 | 2018-04-10 | 陶氏环球技术有限责任公司 | 用于从反应产物混合物中回收酯化纤维素醚的方法 |
KR102286952B1 (ko) * | 2013-12-31 | 2021-08-09 | 롯데정밀화학 주식회사 | 입도분포가 조절된 히드록시프로필 메틸셀룰로오스 아세테이트 숙시네이트(hpmcas) 입자의 제조방법 및 hpmcas 분말 |
US10759873B2 (en) | 2014-02-20 | 2020-09-01 | Dow Global Technologies Llc | Esterified cellulose ethers of high molecular weight and homogeneity |
KR20170045249A (ko) * | 2014-08-27 | 2017-04-26 | 다우 글로벌 테크놀로지스 엘엘씨 | 낮은 아세톤-불용성 함량의 에스테르화된 셀룰로오스 에테르 |
AU2015317358A1 (en) * | 2014-09-19 | 2017-04-27 | Board Of Regents, The University Of Texas System | Methods of preparing extrudates |
CN104311674A (zh) * | 2014-10-17 | 2015-01-28 | 广东东阳光药业有限公司 | 一种混合酯的制备方法 |
CN107074980A (zh) * | 2014-10-31 | 2017-08-18 | 陶氏环球技术有限责任公司 | 制备纤维素醚的酯的方法 |
CN107074979B (zh) * | 2014-10-31 | 2019-07-19 | 陶氏环球技术有限责任公司 | 用于产生乙酸纤维素醚丁二酸酯的方法 |
WO2016069343A1 (en) | 2014-10-31 | 2016-05-06 | Dow Global Technologies Llc | Efficient process for preparing an ester of a cellulose ether |
JP6203702B2 (ja) | 2014-11-18 | 2017-09-27 | 信越化学工業株式会社 | ヒプロメロース酢酸エステルコハク酸エステルを用いたスプレードライ用溶液及び固体分散体の製造方法 |
JP6295380B2 (ja) * | 2015-03-16 | 2018-03-14 | ダウ グローバル テクノロジーズ エルエルシー | 脂肪族カルボン酸の存在下でエステル化セルロースエーテルを調製するためのプロセス |
KR20170128350A (ko) * | 2015-03-16 | 2017-11-22 | 다우 글로벌 테크놀로지스 엘엘씨 | 에스테르화된 셀룰로오스 에테르의 수용액 |
KR20170128371A (ko) * | 2015-03-16 | 2017-11-22 | 다우 글로벌 테크놀로지스 엘엘씨 | 수용성 에스테르화된 셀룰로오스 에테르 |
BR112017018367A2 (pt) * | 2015-03-16 | 2018-04-10 | Dow Global Technologies Llc | gelificação de éteres de celulose esterificados |
WO2016148977A1 (en) | 2015-03-16 | 2016-09-22 | Dow Global Technologies Llc | Water-soluble esterified cellulose ethers having a low degree of neutralization |
JP6725534B2 (ja) | 2015-05-15 | 2020-07-22 | ダウ グローバル テクノロジーズ エルエルシー | 極めて高い分子量及び低い粘度のエステル化セルロースエーテルの生成プロセス |
BR112017023845A2 (pt) | 2015-05-15 | 2018-07-31 | Dow Global Technologies Llc | processo de preparação de um éter de celulose esterificado de peso molecular elevado |
EP3328899B1 (en) * | 2015-07-28 | 2019-06-19 | Dow Global Technologies LLC | Process for producing dispersion of esterified cellulose ether |
WO2017058973A1 (en) * | 2015-10-02 | 2017-04-06 | Dow Global Technologies Llc | Aqueous composition comprising dispersed esterified cellulose ether |
CN108348466A (zh) * | 2015-12-08 | 2018-07-31 | 陶氏环球技术有限责任公司 | 包含纤维素醚和水溶性酯化纤维素醚的组合物 |
US9884922B2 (en) * | 2016-03-11 | 2018-02-06 | Shin-Etsu Chemical Co., Ltd. | Hypromellose acetate succinate, method for producing the same and composition containing the same |
AU2017248828A1 (en) | 2016-04-15 | 2018-11-01 | Janssen Sciences Ireland Uc | Combinations and methods comprising a capsid assembly inhibitor |
GB201609222D0 (en) | 2016-05-25 | 2016-07-06 | F2G Ltd | Pharmaceutical formulation |
KR20190069446A (ko) * | 2016-10-18 | 2019-06-19 | 다우 글로벌 테크놀로지스 엘엘씨 | 에스터화된 셀룰로스 에터를 제조하는 효율적인 공정 |
US10888525B2 (en) * | 2016-11-02 | 2021-01-12 | Shin-Etsu Chemical Co., Ltd. | Hypromellose acetate succinate and method for producing the same |
MX2019010712A (es) * | 2017-03-17 | 2019-10-21 | Dow Global Technologies Llc | Proceso para recuperar un eter de celulosa esterificado a partir de una mezcla de producto de reaccion. |
BR112020007972A2 (pt) * | 2017-10-27 | 2020-10-20 | Plexxikon, Inc. | formulações de composto que modula quinases |
EA202092171A1 (ru) | 2018-03-14 | 2020-12-01 | Янссен Сайенсиз Айрлэнд Анлимитед Компани | Схема дозирования модулятора сборки капсида |
US11819503B2 (en) | 2019-04-23 | 2023-11-21 | F2G Ltd | Method of treating coccidioides infection |
CN115651085B (zh) * | 2022-11-14 | 2023-11-17 | 乳源东阳光药业有限公司 | 一种醋酸羟丙甲纤维素琥珀酸酯的纯化方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4226981A (en) | 1977-09-28 | 1980-10-07 | Shin-Etsu Chemical Co., Ltd. | Ether-ester derivatives of cellulose and their applications |
JP2528706B2 (ja) | 1988-05-30 | 1996-08-28 | ゼリア新薬工業株式会社 | ジヒドロピリジン化合物の製剤組成物 |
EP1741424B1 (en) * | 1997-08-11 | 2018-10-03 | Pfizer Products Inc. | Solid pharmaceutical dispersions with enhanced bioavailabilty |
EP0901786B1 (en) * | 1997-08-11 | 2007-06-13 | Pfizer Products Inc. | Solid pharmaceutical dispersions with enhanced bioavailability |
WO2002038126A2 (en) * | 2000-11-08 | 2002-05-16 | Aeromatic-Fielder Ag | A process for production of particles for pharmaceutical compositions having increased bioavailability |
WO2005115330A2 (en) * | 2004-05-28 | 2005-12-08 | Pfizer Products Inc. | Pharmaceutical compositions with enhanced performance |
WO2007029660A1 (ja) * | 2005-09-06 | 2007-03-15 | Astellas Pharma Inc. | 腸溶性基剤が表面に吸着した難溶性薬物の微小粒子 |
EP1942872A2 (en) * | 2005-11-04 | 2008-07-16 | Eastman Chemical Company | Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents |
-
2011
- 2011-06-13 KR KR1020137000834A patent/KR101807338B1/ko active IP Right Grant
- 2011-06-13 US US13/702,331 patent/US9040033B2/en not_active Expired - Fee Related
- 2011-06-13 BR BR112012031667A patent/BR112012031667A2/pt not_active Application Discontinuation
- 2011-06-13 CN CN201180035955.5A patent/CN103153343B/zh not_active Expired - Fee Related
- 2011-06-13 EP EP11726036.4A patent/EP2579896B1/en not_active Revoked
- 2011-06-13 WO PCT/US2011/040222 patent/WO2011159626A1/en active Application Filing
- 2011-06-13 MX MX2012014849A patent/MX2012014849A/es active IP Right Grant
- 2011-06-13 JP JP2013515418A patent/JP5792807B2/ja not_active Expired - Fee Related
- 2011-06-13 CA CA2801712A patent/CA2801712A1/en not_active Abandoned
-
2012
- 2012-12-12 IL IL223607A patent/IL223607A/en active IP Right Grant
- 2012-12-14 CO CO12226832A patent/CO6660473A2/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CN103153343A (zh) | 2013-06-12 |
WO2011159626A1 (en) | 2011-12-22 |
US9040033B2 (en) | 2015-05-26 |
JP2013532151A (ja) | 2013-08-15 |
IL223607A (en) | 2016-04-21 |
CO6660473A2 (es) | 2013-04-30 |
CN103153343B (zh) | 2015-02-11 |
US20130102691A1 (en) | 2013-04-25 |
KR101807338B1 (ko) | 2018-01-10 |
CA2801712A1 (en) | 2011-12-22 |
MX2012014849A (es) | 2013-05-01 |
EP2579896A1 (en) | 2013-04-17 |
JP5792807B2 (ja) | 2015-10-14 |
KR20130109102A (ko) | 2013-10-07 |
EP2579896B1 (en) | 2016-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012031667A2 (pt) | composição | |
DK2640893T4 (da) | Sammensætninger | |
BR112012032683A2 (pt) | composição | |
BR112012028556A2 (pt) | Indóis | |
DE102011100241A8 (de) | Nitridhalbleiterbauteil | |
DK3225404T3 (da) | Fluidpatron | |
CR20130111A (es) | Triazina-oxidiazoles | |
DE10170954T8 (de) | Mikrowellendruckgarer | |
DE112011104226A5 (de) | Käfigmutter | |
DE102011117046A8 (de) | Doppelkupplungswindungsgetriebe | |
BR112012032980A2 (pt) | composição | |
DE112011101226A5 (de) | Linearwegmesssystem | |
DE112011102080A5 (de) | Kupplungszentralausrücker | |
DK2539163T3 (da) | Dækventil | |
DK2442899T3 (da) | Rotorskive | |
DE112011102711A5 (de) | Hydrostataktor | |
DK2448659T3 (da) | Rotorskive | |
DK2447426T3 (da) | Vaske-WC | |
DK2553004T3 (da) | Sammensatte materialer | |
DE102010019119B8 (de) | Cuttermesser | |
DE112010005518A5 (de) | Dichtungsmanchette | |
DE102010038420A8 (de) | Reinigungungsvorrichtung | |
DK2596072T3 (da) | Bor-forbindelses-suspension | |
DK2521486T3 (da) | Palpometer | |
CO6801789A2 (es) | N-hetarilmetil pirazolilcarboxamidas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |